Low-Dose Tirzepatide: Short-Term Effects on Lipids, Glucose, and Inflammation
Short-term low-dose tirzepatide improved lipid profiles, glucose homeostasis, and inflammatory markers, showing metabolic benefits begin even at starting doses.
Quick Facts
What This Study Found
Short-term low-dose tirzepatide improved lipid profiles, glucose homeostasis, and inflammatory markers, showing metabolic benefits begin even at starting doses.
Key Numbers
Specific numerical changes not detailed in abstract; study measured lipids, glucose parameters, and hepatic steatosis index at baseline and follow-up.
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Short-term low-dose tirzepatide improved lipid profiles, glucose homeostasis, and inflammatory marke
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.
- Published In:
- Journal of diabetes and its complications, 39(12), 109181 (2025)
- Authors:
- Angelopoulos, Nikolaos(2), Livadas, Sarantis(2), Androulakis, Ioannis(2), Petkova, Valentina, Rizoulis, Andreas, Boniakos, Anastasios, Paparodis, Rodis, Tzoulis, Ploutarchos, Mentzelopoulou, Voula, Florakis, Dimos, Fousteris, Evangelos, Korakovouni, Areti, Zianni, Dimitra, Mouslech, Zadalla, Rizzo, Manfredi, Mikhailidis, Dimitri P, Anagnostis, Panagiotis
- Database ID:
- RPEP-09949
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Short-term low-dose tirzepatide improved lipid profiles, glucose homeostasis, and inflammatory markers, showing metabolic benefits begin even at starting doses.
How reliable?
Consult publication.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09949APA
Angelopoulos, Nikolaos; Livadas, Sarantis; Androulakis, Ioannis; Petkova, Valentina; Rizoulis, Andreas; Boniakos, Anastasios; Paparodis, Rodis; Tzoulis, Ploutarchos; Mentzelopoulou, Voula; Florakis, Dimos; Fousteris, Evangelos; Korakovouni, Areti; Zianni, Dimitra; Mouslech, Zadalla; Rizzo, Manfredi; Mikhailidis, Dimitri P; Anagnostis, Panagiotis. (2025). Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.. Journal of diabetes and its complications, 39(12), 109181. https://doi.org/10.1016/j.jdiacomp.2025.109181
MLA
Angelopoulos, Nikolaos, et al. "Short-term effects of low-dose tirzepatide on lipid profile, glucose homeostasis and hepatic steatosis index in adults with obesity, but without diabetes mellitus: a prospective observational study.." Journal of diabetes and its complications, 2025. https://doi.org/10.1016/j.jdiacomp.2025.109181
RethinkPeptides
RethinkPeptides Research Database. "Short-term effects of low-dose tirzepatide on lipid profile,..." RPEP-09949. Retrieved from https://rethinkpeptides.com/research/angelopoulos-2025-shortterm-effects-of-lowdose
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.